Yes, computerized systems validations are reviewed during drug quality audits in Japan. Regulatory authorities, such as the Pharmaceuticals and Medical Devices Agency (PMDA), assess these validations to ensure compliance with Good Manufacturing Practices (GMP). This ensures data integrity, system reliability, and product quality throughout the drug manufacturing process.